Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Ciclesonide
Takeda Pharmaceuticals Australia Pty Ltd
Medicine Registered
ALVESCO ® Version 3 Page 1 of 4 _ _ ALVESCO ® _CICLESONIDE _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Alvesco. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. You should ensure that you speak to your pharmacist or doctor to obtain the most up to date information on this medicine. You can also download the most up to date leaflet from http://www.takedaaustralia.com.au. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits he/she expects it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ALVESCO IS USED FOR Alvesco is inhaled into the lungs for the treatment of asthma. Asthma is a disease where the lining of the lungs becomes inflamed (red and swollen), making it difficult to breathe. Alvesco contains a medicine called ciclesonide, which belongs to a family of medicines called corticosteroids. Alvesco metered dose inhalers deliver a measured amount of ciclesonide, which acts directly on your air passages to reduce inflammation and help keep the air passages open. In doing so, this medication helps to improve your condition and to prevent asthma attacks from occurring. It is a ‘preventer’ and needs to be taken regularly. Alvesco will NOT Læs hele dokumentet